Adenocarcinoma of the Rectum Completed Phase 1 / 2 Trials for Semaxanib (DB06436)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005818SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerTreatment